2011
DOI: 10.1111/j.1365-2443.2011.01539.x
|View full text |Cite
|
Sign up to set email alerts
|

Enhancement of B‐cell receptor signaling by a point mutation of adaptor protein 3BP2 identified in human inherited disease cherubism

Abstract: Tyrosine phosphorylation of adaptor protein c‐Abl‐Src homology 3 (SH3) domain‐binding protein‐2 (3BP2, also referred to SH3BP2) positively regulates the B‐cell antigen receptor (BCR)‐mediated signal transduction, leading to the activation of nuclear factor of activated T cells (NFAT). Here we showed the effect of the proline to arginine substitution of 3BP2 in which is the most common mutation in patients with cherubism (P418R) on B‐cell receptor signaling. Comparing to the wild type, overexpression of the mut… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
8
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
7

Relationship

4
3

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 31 publications
0
8
0
Order By: Relevance
“…After the stimulation, cells were washed with ice-cold PBS twice and solubilized in the lysis buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 10 mM EDTA, 100 mM NaF, 1 mM Na 3 VO 4 , 1 mM PMSF, and 2 g/ml aprotinin) containing 1% Triton X-100. Preparation of detergentsoluble cell lysates, immunoprecipitation, and immunoblotting were performed as described previously (32)(33)(34). Pull-down Assay-The GST-rat Syk-SH2 (both N-and C-terminal SH2 domains) expression construct was a gift from Dr. Reuben P. Siraganian.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…After the stimulation, cells were washed with ice-cold PBS twice and solubilized in the lysis buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 10 mM EDTA, 100 mM NaF, 1 mM Na 3 VO 4 , 1 mM PMSF, and 2 g/ml aprotinin) containing 1% Triton X-100. Preparation of detergentsoluble cell lysates, immunoprecipitation, and immunoblotting were performed as described previously (32)(33)(34). Pull-down Assay-The GST-rat Syk-SH2 (both N-and C-terminal SH2 domains) expression construct was a gift from Dr. Reuben P. Siraganian.…”
Section: Methodsmentioning
confidence: 99%
“…5 ϫ 10 6 cells were incubated without or with 100 g/ml curdlan in medium and were solubilized with the lysis buffer containing 1% Triton X-100. In vitro binding experiments were performed as described previously (32)(33)(34).…”
Section: Methodsmentioning
confidence: 99%
“…In some experiments, Syk inhibitors (R406 and BAY61-3606) were added to the culture medium before stimulation. Preparation of cell lysates and immunoprecipitation were performed as described previously165657585960.…”
Section: Methodsmentioning
confidence: 99%
“…Proteins were visualized using enhanced chemiluminesence reagent (Western Lightning Plus-ECL, Perkin Elmer Life Sciences, Waltham, MA). The antibodies bound to membrane were stripped and reprobed with the other antibodies as described165657585960.…”
Section: Methodsmentioning
confidence: 99%
“…B-lymphoid leukemia BJAB cells were kindly provided from Dr. Satoshi Ishido (RIKEN, Yokohama, Japan) [13] and maintained as described previously [14]. For the stable transfection of BJAB cells, 6 µg of linearized pEF1A-NS5A(Con1)-Myc-His was transfected into 5×10 6 cells/500 µl of cells by electroporation (240 V, 950 µF).…”
Section: Methodsmentioning
confidence: 99%